Plasma concentrations of maraviroc and raltegravir after dual therapy in patients with long-term suppressed viraemia: ROCnRAL ANRS 157 study.
AP-HP, Clinical Pharmacology Department, Bichat Hospital and EA4409 Paris 7 University, Paris, France minh.le@bch.aphp.fr.
Minh Patrick
MP
Lê
Hôpital Pitié-Salpêtrière, INSERM-Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Paris, France.
Cathia
C
Soulié
AP-HP, Epidemiology Department, Pitié-Salpêtrière Hospital and INSERM U943 Paris 6 University, Paris, France.
Lambert
L
Assoumou
AP-HP, Tropical Infectious Diseases Department, Pitié-Salpêtrière Hospital and INSERM U943 Paris 6 University, Paris, France.
Marc-Antoine
MA
Valantin
AP-HP, Infectious Diseases Department, Necker Hospital, Necker-Pasteur Infectiology Center, Paris-Descartes University, Sorbonne Paris Cité, and IHU Imagine, Paris, France.
Claudine
C
Duvivier
AP-HP, Infectious Diseases Department, Tenon Hospital, Paris, France.
Julie
J
Chas
AP-HP, Infectious Diseases Department, Saint-Louis Hospital, Paris, France.
Diane
D
Ponscarme
Hôpital Pitié-Salpêtrière, INSERM-Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Paris, France.
Anne-Geneviève
AG
Marcelin
Hôpital Pitié-Salpêtrière, INSERM-Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Paris, France.
Vincent
V
Calvez
AP-HP, Tropical Infectious Diseases Department, Pitié-Salpêtrière Hospital and INSERM U943 Paris 6 University, Paris, France.
Christine
C
Katlama
AP-HP, Clinical Pharmacology Department, Bichat Hospital and EA4409 Paris 7 University, Paris, France.
Gilles
G
Peytavin
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D002853:Chromatography, Liquid; D003510:Cyclohexanes / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004359:Drug Therapy, Combination / Q000379:methods; D005260:Female; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D008297:Male; D000077592:Maraviroc; D008875:Middle Aged; D010949:Plasma / Q000737:chemistry*; D000068898:Raltegravir Potassium / Q000008:administration & dosage / Q000493:pharmacokinetics*; D053719:Tandem Mass Spectrometry; D014230:Triazoles / Q000008:administration & dosage / Q000493:pharmacokinetics*
D019380:Anti-HIV Agents; D003510:Cyclohexanes; D014230:Triazoles; D000068898:Raltegravir Potassium; D000077592:Maraviroc
NNRTIs; NRTIs; PI-sparing strategies